WATCH Drägerwerk AG & Co. KGaA (DRW3.DE)
Healthcare · Medical Devices · GER · Germany
45
Final Score
-191.9%
Margin of Safety
56
Quality Score
€114.80
Current Price
€2.2B
Market Cap
Key Metrics
Pe Ratio
12.62
Forward Pe
13.01
Pb Ratio
1.30
Ev Ebitda
7.38
Roe
10.9%
Gross Margin
45.7%
Operating Margin
4.4%
Net Margin
4.8%
Dividend Yield
202.0%
Debt To Equity
23.37
Current Ratio
2.05
Beta
0.63
📈 Trend Charts
Revenue Trend
EPS Trend
Net Income Trend
Free Cash Flow Trend
Intrinsic Value Estimates
Low
€31.46
Base
€39.33
High
€47.20
Pipeline Stage Details
Stage A — Hard Filters ✅
Pe Ratio
12.62
Eps Positive Years
3.00
Eps Lookback
4.00
Fcf Positive Years
3.00
Fcf Lookback
4.00
Debt To Equity
0.23
Current Ratio
2.05
Dilution Cagr
0.00
Stage B — Quality Score: 56/100
Stage C — Cyclicality: HIGH
Normalized EPS
€4.11
Stage F — Final Score Breakdown
| Component | Weighted Score |
|---|---|
| Valuation | 3.0 |
| Earnings Quality | 14.0 |
| Balance Sheet | 18.0 |
| Stability | 4.5 |
| Moat Proxies | 5.8 |
Top Drivers
- Reasonable P/E of 12.6x — below long-run market average (~15-17x), suggesting the stock is not overpriced.
- Fortress balance sheet: D/E of 0.23x (conservative) and current ratio of 2.05x — ample liquidity and low financial risk. Graham emphasis on capital preservation.
Top Risks
- Cyclical business at potentially peak earnings — if the cycle turns, earnings could drop significantly and the stock may become much less cheap than it appears today.
Financial History
| Year | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2022 | €3.0B | €1.2B | €-79.8M | €-64.6M | €-3.47 |
| 2023 | €3.4B | €1.5B | €184.1M | €110.4M | €5.86 |
| 2024 | €3.4B | €1.5B | €180.0M | €124.4M | €6.61 |
| 2025 | €3.5B | €1.6B | €231.6M | €139.5M | €7.42 |
Cash Flow History
| Year | Operating CF | CapEx | Free Cash Flow |
|---|---|---|---|
| 2021 | N/A | N/A | N/A |
| 2022 | €-144.2M | €-86.9M | €-231.1M |
| 2023 | €189.7M | €-68.2M | €121.5M |
| 2024 | €167.3M | €-63.8M | €103.5M |
| 2025 | €238.3M | €-80.7M | €157.6M |